• Spatial Proteomics for Smarter Brain Probes

  2026-08-25

  This study develops therapeutic-loaded titania nanotube arrays as multifunctional coatings for intracortical microelectrodes and uses spatial proteomics to resolve local neuroinflammatory responses around the implant. The work provides design guidance for coating placement while linking antimicrobial control, localized drug release, neuronal preservation, and immune response modulation.

• 4-Hydroxytamoxifen: Protocols and QC

  2026-08-25

  4-Hydroxytamoxifen (SKU B6167) provides a DMSO-soluble estrogen receptor modulator for controlled in vitro and selected in vivo research workflows, including cancer models, apoptosis assays, and cardiac myocyte studies. It should not be selected for protocols that require aqueous or ethanol solubility, and its solid-state storage and vehicle controls require careful management.

• Lopinavir (A8204): Reliable Assay Design

  2026-08-24

  Learn how Lopinavir (SKU A8204) can support reproducible cell-based antiviral, viability, and cytotoxicity workflows. This scenario-driven guide connects HIV protease inhibition data with practical solvent, concentration, serum, interpretation, and vendor-selection decisions.

• BH3 Mimetics and Chemotherapy-Induced Senescence

  2026-08-24

  The reference study shows that chemotherapy-induced senescent breast cancer cells can remain a biologically active reservoir for relapse in TP53 wild-type tumors. By using BH3 mimetics after chemotherapy, the investigators selectively triggered apoptosis in senescent cells, improved tumor regression, and extended survival in a mouse model, while also defining BCL-XL and MCL1 dependence as important determinants of response.

• JXY, TLR4, and M1 Polarization in CAC

  2026-08-23

  Liu et al. show that Jiedu Xiaozheng Yin suppresses colitis-associated colorectal cancer in mice while shifting macrophages toward an M1-like state through TLR4-associated signaling. The study integrates pathological assessment, macrophage phenotyping, functional assays, and pharmacological pathway perturbation to connect immune remodeling with reduced tumor burden.

• Ceapin-A7: Mapping ER Stress to Cell Fate

  2026-08-22

  A translational framework for using Ceapin-A7 to separate ATF6α signaling from the PERK–JAK1–STAT3 axis in ER stress-driven pyroptosis research.

• Naturally Occurring Angiotensin Peptides and Spike Binding

  2026-08-22

  A 2025 study found that naturally occurring angiotensin fragments can alter SARS-CoV-2 spike-protein binding to host receptors, with especially strong effects observed for shorter and N-terminally modified peptides. The work connects renin-angiotensin system peptide processing with viral receptor biology while emphasizing that binding changes require validation in infection, physiological, and clinical models.

• QPRT, P2Y11 Signaling, and Breast Cancer Invasion

  2026-08-21

  The reference study identifies QPRT as a regulator of breast cancer cell invasiveness and links its activity to purinergic signaling and myosin light chain phosphorylation. Genetic and pharmacological experiments suggest a QPRT–P2Y11–Rho/ROCK–PLC/MLCK axis that may help explain how altered NAD+ metabolism is connected to cytoskeletal remodeling.

• Moxidectin–Polyene Synergy in Oral Candidiasis

  2026-08-20

  Ye and colleagues show that moxidectin potentiates amphotericin B and Nystatin by increasing Candida albicans ergosterol, the membrane target of polyenes. Genetic, transcriptomic, biochemical, and mouse-model data support a target-amplification strategy, while the study also defines important limits for translating this approach beyond oral candidiasis.

• MALAT1–miR-125b/STAT3 Axis in Sepsis

  2026-08-20

  The reference study identifies a MALAT1–miR-125b–STAT3 regulatory axis that increases procalcitonin expression in sepsis-associated models. By combining patient samples, LPS-stimulated U937 cells, localization studies, and interaction assays, it provides a mechanistic framework for interpreting PCT regulation while highlighting the need for validation beyond an in vitro system.

• Reserpine (N1867): Practical Lab Workflow

  2026-08-19

  Reserpine (SKU N1867) provides a characterized research compound for controlled neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology workflows. This guide covers preparation, storage, QC, and troubleshooting; the material is for research use only and is not intended for diagnostic, therapeutic, or clinical applications.

• O-GlcNAcylation Regulates Galectin-3 in XEN Differentiation

  2026-08-19

  Gatie and colleagues show that extraembryonic endoderm differentiation is accompanied by reduced global O-GlcNAcylation and a redistribution of galectin-3 toward extracellular secretion. Their experiments distinguish correlation from causation: pharmacologically maintaining O-GlcNAc levels did not prevent embryonic stem cell differentiation, suggesting that this modification is associated with, but is not sufficient to control, XEN lineage commitment.

• Anlotinib hydrochloride in Angiogenesis Assays

  2026-08-18

  Learn how to apply Anlotinib hydrochloride as a multi-target tyrosine kinase inhibitor in endothelial migration, tube formation, and pathway-validation workflows. This practical guide connects receptor-level potency with assay design, controls, troubleshooting, and translational cancer research use cases.

• Dasatinib Monohydrate: Assay Reliability Guide

  2026-08-18

  This scenario-based guide explains how Dasatinib Monohydrate (SKU B5954) can support reproducible viability, proliferation, cytotoxicity, and kinase-inhibition experiments. It connects formulation, dosing design, NET biology, resistance modeling, and practical supplier-selection criteria to evidence from product data and published CML research.

• Stattic: Practical STAT3 Inhibitor Workflows

  2026-08-17

  Stattic enables time-controlled interrogation of STAT3 signaling in tumor-cell assays, with practical applications spanning pathway validation, apoptosis induction, and radiation-response studies. This workflow connects STAT3 inhibition with microbiome-associated cancer mechanisms while emphasizing dose design, assay controls, and troubleshooting.

8106 records 1/541 page Next 12345 下5页 Last page